Page last updated: 2024-10-24

chlorambucil and Cholestasis, Intrahepatic

chlorambucil has been researched along with Cholestasis, Intrahepatic in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Cholestasis, Intrahepatic: Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pichon, N1
Debette-Gratien, M1
Cessot, F1
Paraf, F1
Labrousse, F1
Sautereau, D1
Pillegand, B1

Other Studies

1 other study available for chlorambucil and Cholestasis, Intrahepatic

ArticleYear
[Acute cholestatic hepatitis due to chlorambucil].
    Gastroenterologie clinique et biologique, 2001, Volume: 25, Issue:2

    Topics: Acute Disease; Aged; Antineoplastic Agents, Alkylating; Biopsy, Needle; Chemical and Drug Induced Li

2001